The majority of MEB occurrence is reported in the Finnish population. It is estimated to affect 1 in 50,000 newborns in Finland. MEB is also identified outside of Finland, there were cases of suspected MEB in Japan and Korea. However, worldwide distribution is unclear. According to the European Union, the estimated prevalence of MEB in Europe is 0.12 per 100000.41 Carrier rates Ethnicity Detection Rate Carrier Frequency Finnish >99% 1 in 50 General Population 88% 1 in 500 The frequency of being a carrier of MEB is 1 in 50 in Finland, carriers for MEB commonly shows no signs or symptoms. However, their offsprings will have a higher chance to be affected by MEB.
Muscle–eye–brain disease
Basal ganglia disease
White dot syndromes
Aging brain
Early myoclonic encephalopathy
Neurolathyrism
Leukodystrophy
Wernicke encephalopathy